Access to infertility services in Canada for HIV-positive individuals and couples: a cross-sectional study.
BACKGROUND
Family and pregnancy planning issues are important among human immunodeficiency virus (HIV)-positive individuals and couples. However, access to fertility services may be limited for this population. The objective of this study was to estimate the types of services available in fertility clinics in Canada for these individuals.


METHODS
A survey was sent to all registered fertility clinics in Canada to assess the availability of services (investigations and treatment) for infertility and/or viral transmission risk reduction in achieving pregnancy. The proportion and location of clinics willing to carry out investigations and treatments were determined. Logistic regression analysis was performed to assess differences in response rates, investigations, and treatments by province and by couple scenario.


RESULTS
Completed surveys were received from 23/28 (82%) of clinics across eight Canadian provinces. Seventy-eight per cent (18/23) were willing to accept HIV-positive individuals in consultation, and 52% had actually seen at least one HIV-positive man or woman in the previous year. Clinics in every province were willing to offer infertility investigations, but only clinics located in five provinces were willing to offer fertility treatments. The most commonly available treatment was intrauterine insemination for couples in which the female partner was HIV-positive (52%). Other techniques, such as sperm washing (26%) or in vitro fertilization (17%), were less commonly offered. A smaller number of clinics were willing to offer risk reduction techniques in achieving pregnancy.


CONCLUSIONS
Access to infertility investigations and treatments in Canada is limited and regionally dependent.


BACKGROUND
Registered with ClinicalTrials.gov at http://www.clinicaltrials.gov, registration number NCT00782132.
Yudin
Mark H
MH
The department of Obstetrics and Gynecology, St, Michael's Hospital, Toronto, Ontario, Canada. yudinm@smh.toronto.on.ca.
Shapiro
Heather M
HM
Loutfy
Mona R
MR
BMJ. 2001 Dec 1;323(7324):1285
11731391
Lancet. 1992 Nov 28;340(8831):1317-9
1360037
JAMA. 2002 Jul 10;288(2):189-98
12095383
Contraception. 2005 Jan;71(1):45-50
15639072
Hum Reprod. 2003 Jun;18(6):1244-9
12773453
Aust N Z J Public Health. 2004 Aug;28(4):360-2
15704701
AIDS. 1996;10 Suppl A:S75-82
8883613
AIDS Read. 2000 Oct;10(10):581-7
11068804
Fam Plann Perspect. 2001 Jul-Aug;33(4):144-52, 165
11496931
Obstet Gynecol Clin North Am. 1990 Sep;17(3):651-68
2247296
Hum Reprod Update. 2004 Mar-Apr;10(2):149-62
15073144
N Engl J Med. 2000 Jun 8;342(23):1748-50
10841881
N Engl J Med. 1994 Nov 3;331(18):1173-80
7935654
Lancet. 1997 Mar 22;349(9055):850-1
9121267
J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):484-94
11981365
Fertil Steril. 2002 Feb;77(2):218-22
11821074
Fertil Steril. 1998 Jul;70(1):35-9
9660417
AIDS. 1999 Apr 16;13(6):645-51
10397558
AIDS. 2007 Jan;21 Suppl 1:S83-8
17159593
J Infect Dis. 2001 Feb 15;183(4):539-45
11170978
BMJ. 2001 Mar 10;322(7286):566-7
11238138